NCT05587296 2026-04-16
OASIS-4
Bayer
Phase 3 Active not recruiting
Clinical Trials
101 trialsNCT06440967 2026-04-06
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Astellas Pharma Inc
Phase 3 Active not recruiting
NCT07511660 2026-04-06
MUSE-OVARY
Healing Hope International
Enrolling by invitation
NCT07294339 2026-03-19
ACU-HRBC-HF
Peking University People's Hospital
Phase NA Not yet recruiting
NCT06957691 2026-03-09
Fezo-ADT
Brigham and Women's Hospital
Phase 2 Recruiting
NCT01530373 2026-03-05
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
University of Arkansas
Phase 2 Recruiting
NCT07422727 2026-02-20
COOLVAS
Sligo General Hospital
Phase NA Enrolling by invitation
NCT06552091 2026-02-17
HYBOU
Institut de Cancérologie de Lorraine
Phase NA Recruiting
NCT06972875 2026-02-05
FLASH
University of Vermont
Phase 2 Recruiting
NCT07335224 2026-02-04
MPOWER
Inova Health Care Services
Phase NA Recruiting
NCT06369168 2025-12-15
OhrHit
Kliniken Essen-Mitte
Phase NA Completed
NCT05595213 2025-12-01
Wrist Cooling for Hot Flashes Clinical Trial
Boston University
Phase NA Completed
NCT04821141 2025-10-29
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
University of Kansas Medical Center
Phase 2 Active not recruiting
NCT03580499 2025-10-15
Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy
Thomas Jefferson University
Phase NA Completed
NCT07137221 2025-08-22
FLAIR
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Completed
NCT05071729 2025-07-14
A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally
Bayer
Phase 1 Completed
NCT07054957 2025-07-08
Breast Cancer
Izmir Bakircay University
Phase NA Completed
NCT03572153 2025-06-05
A Mind-Body Intervention for Hot Flash Management
Baylor University
Phase NA Completed
NCT05086705 2025-04-22
EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT04418115 2025-03-10
Fatigue As a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?
Kristiania University College
Phase NA Completed
NCT00667121 2025-02-14
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Mayo Clinic
Completed
NCT01573442 2025-01-28
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT06774885 2025-01-14
ROLE OF FOLIC ACID IN THE MANAGEMENT OF ADJUVANT ENDOCRINE THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS
Future University in Egypt
Phase 3 Not yet recruiting
NCT06415162 2024-05-16
Evaluation of the Effects of Using Cooling Pillowcases, on the Symptoms of Hot Flushes, Sleep and Life Quality
Saglik Bilimleri Universitesi
Phase NA Recruiting
NCT06219902 2024-05-08
A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women
Bayer
Phase 1 Completed
NCT03684096 2024-02-15
Effect of Non-estrogenic Pollen Extract PCC-100 on Hot Flushes
University Hospital, Ghent
Phase NA Completed
NCT06161792 2023-12-08
VMS
Yung Shin Pharm. Ind. Co., Ltd.
Phase 2 Terminated
NCT05069467 2023-11-07
AVAIL
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase NA Unknown
NCT03286257 2023-10-12
Can Exercise Training Reduce the Frequency and Severity of Hot Flushes Associated With Breast Cancer Treatment?
Liverpool John Moores University
Phase NA Completed
NCT00026286 2023-06-15
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
Eastern Cooperative Oncology Group
Phase 3 Completed
NCT02513329 2023-06-05
Stellate Ganglion Block (SGB) For Women for Breast Cancer
Northwestern University
Phase 2 Completed
NCT05816460 2023-05-23
SACS
University College Dublin
Phase NA Unknown
NCT05481528 2023-05-09
A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants
Bayer
Phase 1 Completed
NCT00641303 2023-05-08
Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer
University of Maryland, Baltimore
Phase NA Completed
NCT05760222 2023-03-08
Acu-HOTFLASH
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Unknown
NCT05637671 2023-02-08
Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms
Cairo University
Phase 3 Unknown
NCT03796195 2023-01-25
(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes
Northwestern University
Phase 4 Terminated
NCT05471817 2022-11-22
A Study to Learn How the Study Drug Elinzanetant (BAY 3427080) Affects the Way the Drug Dabigatran Moves Into, Through and Out of the Body in Healthy Male and Female Participants
Bayer
Phase 1 Completed
NCT05613504 2022-11-16
Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.
Nanjing University of Traditional Chinese Medicine
Phase NA Not yet recruiting
NCT03122301 2022-08-09
Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer
Northwestern University
Phase 2 Terminated
NCT05381142 2022-07-27
A Study to Learn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple Doses in Healthy Women Aged 40 to 65 Years
Bayer
Phase 1 Completed
NCT05460819 2022-07-20
Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.
Nanjing University of Traditional Chinese Medicine
Phase NA Not yet recruiting
NCT05351892 2022-07-19
A Study to Learn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male Participants
Bayer
Phase 1 Completed
NCT04892914 2022-04-05
Embr Thermal Device for Hot Flash Management in Prostate Cancer
Embr Labs, Inc.
Phase NA Completed
NCT05061563 2022-03-17
A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults
Bayer
Phase 1 Completed
NCT04414033 2022-01-27
Bubble: A New VR-AI Way of Treatment for Hot Flashes in Women With Breast Cancer
Bar-Ilan University, Israel
Phase NA Completed
NCT00110136 2021-09-29
St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer
Wake Forest University Health Sciences
Phase 2 Terminated
NCT00354432 2021-09-28
Soy Protein/Effexor Hormone Therapy for Prostate Cancer
Wake Forest University Health Sciences
Phase 3 Terminated
NCT03361969 2021-06-18
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.
Pantarhei Oncology B.V.
Phase 2 Completed
NCT02295163 2021-03-10
Stellate Ganglion Block for Hot Flushes in Men Treated With ADT
Rijnstate Hospital
Phase NA Withdrawn